Indian astronaut Shubhanshu Shukla is part of the Ax-4 mission studying diabetes in space. This research could transform diabetes care on Earth and enable diabetics to travel safely in space.

Indian astronaut Shubhanshu Shukla’s Ax-4 mission aboard the ISS is studying how microgravity affects glucose metabolism. The ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Houston’s Axiom Space launched its fourth human spaceflight mission on Wednesday. One of the mission’s experiments hopes to ...

Discover how the Axiom-4 mission to the ISS is revolutionizing diabetes treatment with groundbreaking research on glucose ...

Axiom-4 astronauts are set to study insulin behaviour in microgravity, potentially transforming diabetes treatment and aiding ...

The market is driven by rising diabetes prevalence worldwide and increasing adoption of wearable and connected devices ...

During their 14-day stay aboard the orbital lab, some astronauts on the Axiom-4 mission will be wearing continuous glucose ...

AAs India’s astronaut Shubhanshu Shukla has blasted off into space on the Axiom-4 mission, he will be part of several medical ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...